Cargando…
Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial
BACKGROUND: Cardiovascular disease in particular acute coronary syndrome (ACS) is remained one of the most cause of morbidity and mortality, annually. Considering inflammatory pathway of atherosclerosis, colchicine as an anti-inflammatory drug is introduced to be effective in pathogenesis, prognosis...
Autores principales: | Akrami, Mehdi, Izadpanah, Peyman, Bazrafshan, Mehdi, Hatamipour, Unes, Nouraein, Navid, Drissi, Hamed Bazrafshan, Manafi, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650300/ https://www.ncbi.nlm.nih.gov/pubmed/34876021 http://dx.doi.org/10.1186/s12872-021-02393-9 |
Ejemplares similares
-
Ventricular repolarization indicators in risk stratification of decompensated heart failure patients with ventricular systolic dysfunction
por: Hatamnejad, Mohammad Reza, et al.
Publicado: (2022) -
The potential of HEART score to detect the severity of coronary artery disease according to SYNTAX score
por: Salimi, Amirhossein, et al.
Publicado: (2023) -
Electrocardiographic characteristics of cirrhotic patients and their association with Child‐Pugh score
por: Jahangiri, Soodeh, et al.
Publicado: (2023) -
Face-to-face, online, or blended: which method is more effective in teaching electrocardiogram to medical students
por: Bazrgar, Aida, et al.
Publicado: (2023) -
Impacts of opium addiction on patterns of angiographic findings in patients with acute coronary syndrome
por: Abdiardekani, Alireza, et al.
Publicado: (2022)